Amerika Serikat - Inggris - NLM (National Library of Medicine)

par pharmaceutical, inc. - sodium phenylbutyrate (unii: nt6k61736t) (phenylbutyric acid - unii:7wy7ybi87e) - sodium phenylbutyrate 500 mg - sodium phenylbutyrate tablets is indicated as adjunctive therapy in the chronic management of patients with urea cycle disorders involving deficiencies of carbamylphosphate synthetase (cps), ornithine transcarbamylase (otc), or argininosuccinic acid synthetase (as). it is indicated in all patients with neonatal-onset deficiency (complete enzymatic deficiency, presenting within the first 28 days of life). it is also indicated in patients with late-onset disease (partial enzymatic deficiency, presenting after the first month of life) who have a history of hyperammonemic encephalopathy. it is important that the diagnosis be made early and treatment initiated immediately to improve survival. any episode of acute hyperammonemia should be treated as a life-threatening emergency. sodium phenylbutyrate tablets must be combined with dietary protein restriction and, in some cases, essential amino acid supplementation. (see nutritional supplementation subsection of the dosage and administration section.) previously, ne

Amerika Serikat - Inggris - NLM (National Library of Medicine)

rebel distributors corp - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - dexamethasone phosphate 1 mg in 1 ml - for the treatment of the following conditions: ophthalmic: steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical or thermal burns, or penetration of foreign bodies. otic: steroid responsive inflammatory conditions of the external auditory meatus, such as allergic otitis externa, selected purulent and nonpurulent infective otitis externa when the hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation. epithelial herpes simplex keratitis (dendritic keratitis). acute infectious stages of vaccinia, varicella and many other viral diseases of the cornea and conjunctiva. mycobacterial infection of the eye. funga

Amerika Serikat - Inggris - NLM (National Library of Medicine)

deseret biologicals, inc. - .alpha.-ketoglutaric acid (unii: 8id597z82x) (.alpha.-ketoglutaric acid - unii:8id597z82x), adenosine triphosphate disodium (unii: 5l51b4dr1g) (adenosine triphosphate - unii:8l70q75fxe), formic acid (unii: 0yiw783rg1) (formic acid - unii:0yiw783rg1), malic acid (unii: 817l1n4ckp) (malic acid - unii:817l1n4ckp), lactic acid, l- (unii: f9s9ffu82n) (lactic acid, l- - unii:f9s9ffu82n), solanum dulcamara top (unii: kps1b1162n) (solanum dulcamara top - unii:kps1b1162n), hyoscyamus niger (unii: 4wrk2153h3) (hyoscy - .alpha.-ketoglutaric acid 6 [hp_x] in 1 ml - for temporary relief of symptoms related to attention deficit including hyperactivity and poor concentration.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to attention deficit including hyperactivity and poor concentration.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

anazaohealth corporation - sodium pyrophosphate (unii: o352864b8z) (pyrophosphoric acid - unii:4e862e7grq) - sodium pyrophosphate 27.6 mg - stannous pyrophosphate is indicated as a blood pool imaging agent which may be used for gated pool imaging and for the detection of sites of gastrointestinal bleeding. when administered intravenously, 15-30 minutes prior to intravenous administration of sodium pertechnetate tc99m for in vivo red blood cell labeling, approximately 75 percent of the injected activity remains in the blood pool. the modified in vivo/in vitro red blood cell labeling method may also be used for blood pool imaging. it is also indicated as a skeletal imaging agent used to demonstrate areas of altered osteogenesis, and a cardiac imaging agent used as an adjunct in the diagnosis of acute myocardial infarction.

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

alturix ltd - sodium dihydrogen phosphate anhydrous - effervescent tablet - 1.936gram

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - sodium bicarbonate; sodium dihydrogen phosphate dihydrate - suppository - 500mg ; 680mg

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - sodium ascorbate, quantity: 113 mg (equivalent: ascorbic acid, qty 100 mg); folic acid, quantity: 0.4 mg; pyridoxine hydrochloride, quantity: 4.9 mg (equivalent: pyridoxine, qty 4 mg); nicotinamide, quantity: 40 mg; cyanocobalamin, quantity: 5 microgram; thiamine nitrate, quantity: 3.1 mg; biotin, quantity: 60 microgram; sodium pantothenate, quantity: 16.5 mg (equivalent: pantothenic acid, qty 15 mg); riboflavine sodium phosphate, quantity: 4.9 mg (equivalent: riboflavine, qty 3.6 mg) - injection, powder for - excipient ingredients: edetate sodium; methyl hydroxybenzoate; glycine - soluvit n is intended as a supplement in intravenous nutrition in order to meet the daily requirements of the water-soluble vitamins in adults, adolescents, children and infants. fat-soluble vitamins should also be administered to patients receiving prolonged parenteral nutrition.

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - hydrocortisone sodium phosphate - solution for injection - 100mg/1ml

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - hydrocortisone sodium phosphate - solution for injection - 100mg/1ml

Amerika Serikat - Inggris - NLM (National Library of Medicine)

medical purchasing solutions, llc - dexamethasone sodium phosphate (unii: ai9376y64p) (dexamethasone - unii:7s5i7g3jql) - dexamethasone phosphate 10 mg in 1 ml - a. by intravenous or intramuscular injection when oral therapy is not feasible: 1. endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful. shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is suspected. congenital adrenal hyperplasia. nonsuppurative thyroiditis. hypercalcemia associated with cancer. 2. rheumatic disorders: as adjunctive therapy for short-term administration (to tide the patient over an ac